Nomogram Model to Predict the Probability of Ovarian Hyperstimulation Syndrome in the Treatment of Patients With Polycystic Ovary Syndrome

被引:11
|
作者
Li, Fei [1 ,2 ]
Chen, Ying [1 ]
Niu, Aiqin [1 ]
He, Yajing [3 ]
Yan, Ying [4 ]
机构
[1] First Peoples Hosp Shangqiu, Ctr Reprod Med, Shangqiu, Henan, Peoples R China
[2] Zheng Zhou Univ, Ctr Reprod Med, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China
[3] First Peoples Hosp Shangqiu, Dept Pathol, Shangqiu, Henan, Peoples R China
[4] First Peoples Hosp Shangqiu, Dept Mol Biol, Shangqiu, Henan, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2021年 / 12卷
基金
中国国家自然科学基金;
关键词
assisted reproductive technology; polycystic ovary syndrome; ovarian hyperstimulation syndrome; risk factors; norman model; NUMBER; IVF; BIRTH; PCOS;
D O I
10.3389/fendo.2021.619059
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The objective of this study was to explore the risk factors of ovarian hyperstimulation syndrome (OHSS) in patients with polycystic ovary syndrome (PCOS) undergoing in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) and to establish a nomogram model evaluate the probability of OHSS in PCOS patients. Methods: We retrospectively analyzed clinical data from 4,351 patients with PCOS receiving IVF/ICSI in our reproductive medical center. The clinical cases were randomly divided into a modeling group (3,231 cases) and a verification group (1,120 cases) according to a ratio of about 3:1. The independent risk factors correlation with the occurrence of OHSS was identified by logistic regression analysis. Based on the selected independent risk factors and correlated regression coefficients, we established a nomogram model to predict the probability of OHSS in PCOS patients, and the predictive accuracy of the model was measured using the area under the receiver operating curve (AUC). Results: Univariate and multivariate logistic regression analyses showed that FSH (OR, 0.901; 95% CI, 0.847-0.958; P<0.001), AMH (OR, 1.259; 95% CI, 1.206-1.315; P<0.001), E2 value on the day of hCG injection (OR, 1.122; 95% CI, 1.021-1.253; P<0.001), total dosage of Gn used (OR, 1.010; 95% CI, 1.002-1.016; P=0.041), and follicle number on the day of hCG injection (OR, 0.134; 95% CI, 1.020-1.261; P=0.020) are the independent risk factors for OHSS in PCOS patients. The AUC of the modeling group is 0.827 (95% CI, 0.795-0.859), and the AUC of the verification group is 0.757 (95% CI, 0.733-0.782). Conclusion: The newly established nomogram model has proven to be a novel tool that can effectively, easily, and intuitively predict the probability of OHSS in the patients with PCOS, by which the clinician can set up a better clinical management strategies for conducting a precise personal therapy.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Coasting may reduce the severity of the ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome
    Ohata, Y
    Harada, T
    Ito, M
    Yoshida, S
    Iwabe, T
    Terakawa, N
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2000, 50 (03) : 186 - 188
  • [2] Recurrent spontaneous ovarian hyperstimulation syndrome associated with polycystic ovary syndrome
    Zalel, Y
    Orvieto, R
    BenRafael, Z
    Homburg, R
    Fischer, O
    Insler, V
    GYNECOLOGICAL ENDOCRINOLOGY, 1995, 9 (04) : 313 - 315
  • [3] Vascular endothelial growth factor, polycystic ovary syndrome, and ovarian hyperstimulation syndrome
    Meldrum, DR
    FERTILITY AND STERILITY, 2002, 78 (06) : 1170 - 1171
  • [4] A proteomic analysis identifies candidate early biomarkers to predict ovarian hyperstimulation syndrome in polycystic ovarian syndrome patients
    Wu, Lan
    Sun, Yazhou
    Wan, Jun
    Luan, Ting
    Cheng, Qing
    Tan, Yong
    MOLECULAR MEDICINE REPORTS, 2017, 16 (01) : 272 - 280
  • [5] OVARIAN HYPERSTIMULATION IN POLYCYSTIC OVARY SYNDROME DURING THERAPY WITH LEUPROLIDE ACETATE
    WALMER, DK
    HANEY, AF
    DODSON, WC
    FERTILITY AND STERILITY, 1989, 52 (05) : 858 - 859
  • [6] Management of infertility and prevention of ovarian hyperstimulation in women with polycystic ovary syndrome
    Homburg, R
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2004, 18 (05) : 773 - 788
  • [7] Role of Serum miRNAs in the Prediction of Ovarian Hyperstimulation Syndrome in Polycystic Ovarian Syndrome Patients
    Zhao, Chun
    Liu, Xiaoguang
    Shi, Zhonghua
    Zhang, Jing
    Zhang, Junqiang
    Jia, Xuemei
    Ling, Xiufeng
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 35 (03) : 1086 - 1094
  • [8] Prediction of Ovarian Hyperstimulation in Patients With Polycystic Ovary Syndrome (PCOS) Treated With Human Menopausal Gonadotrophins
    Sallam, H.
    El-Kaffash, D.
    Abou-Heif, M.
    El-Abd, M.
    Sallam, A.
    Agameya, A.
    FERTILITY AND STERILITY, 2011, 95 (04) : S9 - S9
  • [9] Is it polycystic ovary syndrome causing the hyperstimulation again?
    Karabacak, O
    Girgin, MÖ
    Yucesoy, G
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 179 (03) : 838 - 838
  • [10] Ovarian hyperstimulation after administration of triptorelin therapy to a patient with polycystic ovary syndrome
    Campo, S
    Bezzi, I
    Garcea, N
    FERTILITY AND STERILITY, 2000, 73 (06) : 1256 - 1258